本文選題：多囊卵巢綜合征　切入點(diǎn)：ANRIL　出處：《安徽醫(yī)科大學(xué)》2014年碩士論文　論文類型：學(xué)位論文

【摘要】：目的本研究目的是探究ANRIL多態(tài)性與中國(guó)漢族人群多囊卵巢綜合征的易感性。 方法在中國(guó)漢族女性中收集139例多囊卵巢綜合征患者和141例對(duì)照者，提取DNA，設(shè)計(jì)探針引物通過(guò)實(shí)時(shí)熒光PCR TaqMan探針方法對(duì)INK4區(qū)域反義非編碼RNA(ANRIL)的一個(gè)SNPrs1333049進(jìn)行基因分型分析。 結(jié)果在PCOS患者中，各項(xiàng)生化指標(biāo)和臨床表現(xiàn)在各基因型之間差異無(wú)統(tǒng)計(jì)學(xué)意義。通過(guò)分析TaqMan探針基因分型的結(jié)果，rs1333049位可以分為3種基因型：CC，CG,GG。通過(guò)統(tǒng)計(jì)分析，PCOS患者和對(duì)照者間基因型分布和等位基因頻率差異無(wú)統(tǒng)計(jì)學(xué)意義(2=1.87, P=0.17;2=3.25, P=0.20)。 結(jié)論染色體9p21上rs1333049多態(tài)性與PCOS高雄激素血癥無(wú)關(guān)。 目的為探究CITED2基因在卵巢早衰的疾病發(fā)生過(guò)程中的作用，本研究將在卵巢早衰病人中篩查CITED2基因潛在的突變，以確認(rèn)CITED2基因與該疾病的關(guān)系。 方法收集189例特發(fā)性卵巢早衰患者和200例健康女性對(duì)照的外周血樣，提取DNA后，PCR擴(kuò)增直接測(cè)序探查CITED2基因啟動(dòng)子區(qū)和編碼區(qū)的變異。隨后，構(gòu)建相應(yīng)質(zhì)粒，通過(guò)哺乳動(dòng)物雙雜交,雙螢光素酶報(bào)告實(shí)驗(yàn),亞細(xì)胞定位等功能試驗(yàn)檢驗(yàn)CITED2基因中突變位點(diǎn)的作用。 結(jié)果對(duì)189例卵巢早衰患者和200例健康對(duì)照女性的CITED2基因編碼區(qū)和啟動(dòng)子區(qū)測(cè)序峰圖，進(jìn)行chromas軟件解讀比對(duì)，一位POF患者的CITED2基因編碼區(qū)和啟動(dòng)子區(qū)各發(fā)現(xiàn)一個(gè)突變，分別為c.634AG Met212Val和T-339G，這兩個(gè)突變均未在正常對(duì)照中發(fā)現(xiàn),且這兩個(gè)突變均不在研究熱點(diǎn)區(qū)域。通過(guò)體外功能實(shí)驗(yàn)，，發(fā)現(xiàn)野生型CITED2可以通過(guò)調(diào)節(jié)HIF1-a來(lái)調(diào)控VEGF的表達(dá)。而實(shí)驗(yàn)發(fā)現(xiàn)的編碼區(qū)突變?cè)陔p熒光實(shí)驗(yàn)和哺乳動(dòng)物雙雜交試驗(yàn)中均可通過(guò)競(jìng)爭(zhēng)性抑制HIF1-a與CBP/300結(jié)合，來(lái)恢復(fù)VEGF的表達(dá)。亞細(xì)胞定位可見野生型和突變型CITED2對(duì)于細(xì)胞定位并無(wú)明顯影響。啟動(dòng)子中的突變相較于野生型可以升高基因的表達(dá)。 結(jié)論首次在中國(guó)漢族特發(fā)性POF患者中發(fā)現(xiàn)CITED2基因中的突變，并通過(guò)功能實(shí)驗(yàn)進(jìn)一步明確了突變可能的作用，并由此推斷對(duì)于其可能與POF的發(fā)生相關(guān)。
[Abstract]:Objective to explore the relationship between ANRIL polymorphism and susceptibility to polycystic ovary syndrome (PCOS) in Chinese Han population. Methods A total of 139 polycystic ovary syndrome (PCOS) patients and 141 controls were collected from Han women in China, and a probe primer was designed to analyze a SNPrs1333049 of INK4 region antisense noncoding RNAs by real-time fluorescence PCR TaqMan probe method. Results in PCOS patients, There was no significant difference in biochemical indexes and clinical manifestations among genotypes. The results of TaqMan probe genotyping could be divided into three genotypes: 1: CCG GG. By statistical analysis of genotypes between PCOS patients and controls, the genotypes of rs1333049 could be divided into 3 genotypes. There was no significant difference in distribution and allele frequency (P = 1.87, P = 0.17, P = 0.20, P = 0.20). Conclusion rs1333049 polymorphism on chromosome 9p21 is not associated with PCOS hyperandrogenemia. Objective to investigate the role of CITED2 gene in the pathogenesis of premature ovarian failure (POF). In this study, potential mutations of CITED2 gene were screened in premature ovarian failure patients to confirm the relationship between CITED2 gene and the disease. Methods Peripheral blood samples of 189 patients with idiopathic premature ovarian failure and 200 healthy female controls were collected. After DNA was extracted, the mutation of promoter and coding region of CITED2 gene was detected by direct sequencing. Then the corresponding plasmids were constructed. The function of mutation site in CITED2 gene was tested by mammalian two-hybrid, double-luciferase report and subcellular localization. Results the CITED2 gene coding region and promoter region were sequenced from 189 preterm ovarian failure patients and 200 healthy women, and chromas software was used to analyze and compare. One mutation was found in the CITED2 gene coding region and one in the promoter region in one POF patient, and one mutation was found in the CITED2 gene coding region and promoter region in one POF patient. C. 634AG Met212Val and T-339G. these two mutations were not found in normal control, and neither of them was found in the hot research area. It was found that wild-type CITED2 could regulate the expression of VEGF by regulating HIF1-a, and the coding region mutation could be inhibited by competitive inhibition of HIF1-a binding to CBP/300 in both bifluorescence and mammalian two-hybrid experiments. Subcellular localization showed that wild type and mutant CITED2 had no significant effect on cellular localization. Mutations in promoter could increase gene expression compared with wild type. Conclusion the mutation of CITED2 gene was first found in Chinese Han patients with idiopathic POF, and the possible role of the mutation was further clarified by functional experiments, and it was deduced that the mutation might be related to the occurrence of POF.
【學(xué)位授予單位】：安徽醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類號(hào)】：R711.75

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 徐曉潔;陳靜;;黃體功能不全性不孕不育癥中西醫(yī)研究進(jìn)展[J];中醫(yī)藥臨床雜志;2006年01期

2 王道萍;;黃體功能不健致反復(fù)性早期自然流產(chǎn)34例診治分析[J];中醫(yī)藥臨床雜志;2008年01期

3 季鋼,張玲,朱健生,洪名云;卵子贈(zèng)送技術(shù)在不孕癥治療中的臨床應(yīng)用[J];安徽衛(wèi)生職業(yè)技術(shù)學(xué)院學(xué)報(bào);2005年04期

4 付應(yīng)云;吳麗敏;桑美英;劉雨生;;注射過(guò)程中心理輔導(dǎo)對(duì)體外受精-胚胎移植妊娠結(jié)局的影響[J];安徽醫(yī)學(xué);2010年06期

5 李冬梅;蘆雅蘋;鐘倩;郭江華;黎平;;阿拉瑞林聯(lián)合人絕經(jīng)期促性腺激素治療小卵泡排卵的療效觀察[J];安徽醫(yī)藥;2008年06期

6 王鈺;馬成民;張超;;四種精索靜脈曲張治療方法103療效比較[J];安徽醫(yī)藥;2011年04期

7 梅本華,馬素俠;補(bǔ)腎毓麟湯加克羅米芬治療無(wú)排卵性不孕癥20例[J];安徽中醫(yī)學(xué)院學(xué)報(bào);2000年05期

8 湯美玲;;宮腔鏡聯(lián)合腹腔鏡手術(shù)診治不孕癥48例臨床分析[J];蚌埠醫(yī)學(xué)院學(xué)報(bào);2011年08期

9 金玲麗;中藥配合克羅米酚治療多囊卵巢綜合征致不孕47例臨床觀察[J];浙江中醫(yī)學(xué)院學(xué)報(bào);2003年03期

10 周劍萍;;中藥加克羅米酚治療排卵功能障礙性不孕的臨床觀察[J];浙江中醫(yī)藥大學(xué)學(xué)報(bào);2006年03期

相關(guān)會(huì)議論文 前10條

1 雷磊;羅曼;;促排卵湯對(duì)體外授精-胚胎移植妊娠率的影響[A];第十一次全國(guó)中醫(yī)婦科學(xué)術(shù)大會(huì)論文集[C];2011年

2 倪才方;鄒建偉;趙輝;金泳海;朱曉黎;劉一之;何琦;沈仲姬;;經(jīng)子宮動(dòng)脈灌注和栓塞治療輸卵管妊娠[A];第二屆全國(guó)非血管性與血管性介入新技術(shù)學(xué)術(shù)研討會(huì)暨第三屆介入放射學(xué)新技術(shù)提高班論文匯編[C];2005年

3 何會(huì)霞;袁惠霞;;超聲監(jiān)測(cè)卵泡發(fā)育在治療不孕癥中的作用[A];現(xiàn)代醫(yī)學(xué)診斷指標(biāo)在中醫(yī)藥診斷治療中的應(yīng)用文集[C];2008年

4 蔣學(xué)祿;;宮腔鏡、腹腔鏡聯(lián)合診治輸卵管梗阻64例分析[A];浙江省中西醫(yī)結(jié)合學(xué)會(huì)生殖醫(yī)學(xué)專業(yè)委員會(huì)第二屆第一次年會(huì)暨繼續(xù)教育學(xué)習(xí)班資料匯編[C];2006年

5 歐陽(yáng)紫婷;錢平;陳淑瓊;沈艷;粟泉;;活血通絡(luò)顆粒治療輸卵管炎性不孕癥及對(duì)血液流變學(xué)影響的臨床研究[A];第四屆中醫(yī)藥繼續(xù)教育高峰論壇暨中華中醫(yī)藥學(xué)會(huì)繼續(xù)教育分會(huì)換屆選舉會(huì)議論文集[C];2011年

6 王道萍;;中藥補(bǔ)腎調(diào)周法聯(lián)合西藥治療腎陽(yáng)虛型多囊卵巢綜合征臨床研究[A];第八屆全國(guó)中西醫(yī)結(jié)合婦產(chǎn)科學(xué)術(shù)大會(huì)論文及摘要集[C];2012年

7 陳芊;孫云松;孫選;張斌;徐慧軍;;益腎調(diào)肝Ⅱ號(hào)方對(duì)PCOS模型大鼠卵巢卵泡發(fā)育及LH受體表達(dá)的影響[A];戰(zhàn)略性新興產(chǎn)業(yè)與科技支撐——青島市第十屆學(xué)術(shù)年會(huì)論文集[C];2012年

8 邱t

本文編號(hào)：1615876